IP Verse

Treating Infections With Ceftolozane/Tazobactam In Subjects Having Impaired Renal Function

Patent No. EP3043797 (titled "Treating Infections With Ceftolozane/Tazobactam In Subjects Having Impaired Renal Function") was filed by Merck Sharp & Dohme on Sep 9, 2014. The application was issued on Apr 8, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBDec 21, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3043797

MERCK SHARP & DOHME
Application Number
EP14842042A
Filing Date
Sep 9, 2014
Status
Opposition Rejected
Nov 25, 2022
Publication Date
Apr 8, 2020
External Links
Slate, Register , Google Patents